Reliance Biopharma & Pharmaceuticals Group LLC is a leading Contract Development and Manufacturing Organization (CDMO) dedicated to advancing biopharmaceutical innovation. Our team of experts is passionate about driving success for our partners, offering tailored solutions that meet the unique challenges of today’s healthcare landscape.
We offer a comprehensive range of integrated solutions spanning drug development, clinical trials, and biotech innovation. Our services include contract development and manufacturing (CDMO) for small and large molecules, advanced therapies, clinical trial supply, and commercialization. We also provide cell biology expertise, protein assays, lab instruments and equipment maintenance, training, enterprise-level lab informatics, and financial leasing solutions.
Additionally, our support extends to biotech companies with scalable tools for discovery, development, and commercialization, along with partnering, licensing, food safety inspection, and enterprise services to enhance productivity and ensure quality across all operations.
End-to-End project management excellence.
Advanced GMP-compliant manufacturing technology.
Tailored services for unique project needs.
Ethical operations with minimal environmental impact.
At Reliance Biopharma, we are driven by a commitment to sustainability, ethical practices, and community well-being. Our operations are designed to minimize environmental impact while fostering a diverse and inclusive workplace where innovation thrives.
Browse Reliance Jobs, Vacancies, Programs, and Volunteer positions.
Stay informed with the latest news and insights from Reliance Biopharma. From industry trends to company updates, our blog and news section keeps you connected to what’s happening in the world of biopharmaceuticals.
The biopharmaceutical industry is evolving rapidly, driven by innovations in technology, new therapeutic discoveries, and ever-changing regulatory landscapes. To keep
In the dynamic and fast-paced world of biotechnology, the journey from discovery to commercialization is filled with numerous challenges. As
